PMC:7346000 / 9331-9470 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"279","span":{"begin":67,"end":71},"obj":"Gene"},{"id":"285","span":{"begin":130,"end":138},"obj":"Species"},{"id":"295","span":{"begin":121,"end":129},"obj":"Disease"}],"attributes":[{"id":"A279","pred":"tao:has_database_id","subj":"279","obj":"Gene:3569"},{"id":"A285","pred":"tao:has_database_id","subj":"285","obj":"Tax:9606"},{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"For this reason, ongoing trials are addressing the combined use of IL-6 antagonists and antifungal prophylaxis in severe COVID-19 patients."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T103","span":{"begin":121,"end":129},"obj":"Disease"}],"attributes":[{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"For this reason, ongoing trials are addressing the combined use of IL-6 antagonists and antifungal prophylaxis in severe COVID-19 patients."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T55","span":{"begin":67,"end":69},"obj":"Chemical"},{"id":"T57","span":{"begin":72,"end":83},"obj":"Chemical"},{"id":"T58","span":{"begin":88,"end":98},"obj":"Chemical"}],"attributes":[{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A56","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_35718"}],"text":"For this reason, ongoing trials are addressing the combined use of IL-6 antagonists and antifungal prophylaxis in severe COVID-19 patients."}

{"project":"LitCovid-sentences","denotations":[{"id":"T51","span":{"begin":0,"end":139},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For this reason, ongoing trials are addressing the combined use of IL-6 antagonists and antifungal prophylaxis in severe COVID-19 patients."}